Evidence map›Paper›PMID 40186078›Full record

Observational studyNature medicine2025

Implementation of a national AI technology program on cardiovascular outcomes and the health system.

Timothy A Fairbairn, Liam Mullen, Edward Nicol, Gregory Y H Lip, Matthias Schmitt, Matthew Shaw, Laurence Tidbury, Ian Kemp, Jennifer Crooks, Girvan Burnside and 29 more

Abstract readObservational Study
In one paragraph

Observational study in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Timothy A FairbairnLiverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, Liverpool, UK. tfair@liverpool.ac.uk.ORCID http://orcid.org/0000-0003-1491-6231
Liam MullenLiverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, Liverpool, UK.
Edward NicolRoyal Brompton and Harefield Hospital, Guys and St Thomas' NHS Trust, London, UK.
Gregory Y H LipLiverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, Liverpool, UK.
Matthias SchmittManchester University NHS Foundation Trust, Manchester, UK.ORCID http://orcid.org/0000-0001-8514-0261
Matthew ShawLiverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, Liverpool, UK.
Laurence TidburyLiverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, Liverpool, UK.ORCID http://orcid.org/0000-0002-7748-8791
Ian KempLiverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, Liverpool, UK.
Jennifer CrooksLiverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, Liverpool, UK.
Girvan BurnsideInstitute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
Sumeet SharmaAshford and St Peters Hospital NHS Foundation Trust, London, UK.
Anoop ChauhanBlackpool Teaching Hospitals NHS Foundation Trusts, Blackpool, UK.
Chee LiewBlackpool Teaching Hospitals NHS Foundation Trusts, Blackpool, UK.
Sawan WaidyanathaDudley Group NHS Foundation Trust, Birmingham, UK.
Sri IyengerFrimley Health NHS Foundation Trust, Guildford, UK.
Andrew BealeGreat Western Hospitals NHS Foundation Trust, Swindon, UK.
Imran SunderjiHull University Teaching Hospitals NHS Trust, Hull, UK.
John P GreenwoodLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, UK.ORCID http://orcid.org/0000-0002-2861-0914
Manish MotwaniManchester University NHS Foundation Trust, Manchester, UK.
Anna ReidManchester University NHS Foundation Trust, Manchester, UK.
Anna BeattieNewcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Justin CarterNorth Tees and Hartlepool NHS Foundation Trust, Middlesbrough, UK.ORCID http://orcid.org/0009-0004-2122-2291
Peter HaworthPortsmouth Hospitals NHS Trust, Portsmouth, UK.
Nicholas BellengerRoyal Devon and Exeter Hospital NHS Trust, Exeter, UK.
Benjamin HudsonRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Jonathan RodriguesRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Oliver WatsonSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Vinod VenugopalUnited Lincolnshire Hospitals NHS Trust, Lincoln, UK.
Russell BullUniversity Hospital Dorset NHS Trust, Bournemouth, UK.
Peter O'KaneUniversity Hospital Dorset NHS Trust, Bournemouth, UK.
Aparna DeshpandeUniversity Hospitals of Leicester NHS Trust, Leicester, UK.
Gerald P McCannUniversity Hospitals of Leicester NHS Trust, Leicester, UK.
Simon DuckettUniversity Hospitals of North Midlands NHS Trust, Stoke-On-Trent, UK.
Hatef MansoubiUniversity Hospitals Sussex NHS Foundation Trust, Brighton, UK.
Victoria ParishUniversity Hospitals Sussex NHS Foundation Trust, Brighton, UK.ORCID http://orcid.org/0000-0001-9895-1178
Joban SehmiWest Hertfordshire Hospital NHS Trust, Watford, UK.
Campbell RogersHeartFlow Inc, Mountainview, CA, USA.ORCID http://orcid.org/0000-0003-3955-7650
Sarah MullenHeartFlow Inc, Mountainview, CA, USA.ORCID http://orcid.org/0000-0002-1387-8934
Jonathan Weir-McCalLRoyal Brompton and Harefield Hospital, Guys and St Thomas' NHS Trust, London, UK.ORCID http://orcid.org/0000-0001-5842-842X

Funding

RCUK | Medical Research Council (MRC) MR/T024933/1
6 · The paper itself

Abstract

Coronary artery disease (CAD) is a major cause of ill health and death worldwide. Coronary computed tomographic angiography (CCTA) is the first-line investigation to detect CAD in symptomatic patients. This diagnostic approach risks greater second-line heart tests and treatments at a cost to the patient and health system. The National Health Service funded use of an artificial intelligence (AI) diagnostic tool, computed tomography (CT)-derived fractional flow reserve (FFR-CT), in patients with chest pain to improve physician decision-making and reduce downstream tests. This observational cohort study assessed the impact of FFR-CT on cardiovascular outcomes by including all patients investigated with CCTA during the national AI implementation program at 27 hospitals (CCTA n = 90,553 and FFR-CT n = 7,863). FFR-CT was safe, with no difference in all-cause (n = 1,134 (3.2%) versus 1,612 (2.9%), adjusted-hazard ratio (aHR) 1.00 (0.93-1.08), P = 0.97) or cardiovascular mortality (n = 465 (1.3%) versus 617 (1.1%), aHR 0.96 (0.85-1.08), P = 0.48), while reducing invasive coronary angiograms (n = 5,720 (16%) versus 8,183 (14.9%), aHR 0.93 (0.90-0.97), P < 0.001) and noninvasive cardiac tests (189/1,000 patients versus 167/1,000), P < 0.001). Implementation of an AI-diagnostic tool as part of a health intervention program was safe and beneficial to the patient pathway and health system with fewer cardiac tests at 2 years.

Indexed as

Artificial IntelligenceCardiovascular DiseasesCoronary Artery DiseaseAgedComputed Tomography AngiographyCoronary AngiographyFemaleFractional Flow Reserve, MyocardialHumansMaleMiddle Aged

Identifiers

PMID40186078
PMCPMC12176617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.